Chemical Component Summary | |
---|---|
Name | Citarinostat |
Synonyms | 2-[(2-chlorophenyl)(phenyl)amino]-N-[7-(hydroxyamino)-7-oxoheptyl]pyrimidine-5-carboxamide |
Identifiers | 2-[(2-chlorophenyl)-phenyl-amino]-~{N}-[7-(oxidanylamino)-7-oxidanylidene-heptyl]pyrimidine-5-carboxamide |
Formula | C24 H26 Cl N5 O3 |
Molecular Weight | 467.948 |
Type | NON-POLYMER |
Isomeric SMILES | c1ccc(cc1)N(c2ccccc2Cl)c3ncc(cn3)C(=O)NCCCCCCC(=O)NO |
InChI | InChI=1S/C24H26ClN5O3/c25-20-12-7-8-13-21(20)30(19-10-4-3-5-11-19)24-27-16-18(17-28-24)23(32)26-15-9-2-1-6-14-22(31)29-33/h3-5,7-8,10-13,16-17,33H,1-2,6,9,14-15H2,(H,26,32)(H,29,31) |
InChIKey | VLIUIBXPEDFJRF-UHFFFAOYSA-N |
Chemical Details | |
---|---|
Formal Charge | 0 |
Atom Count | 59 |
Chiral Atom Count | 0 |
Bond Count | 61 |
Aromatic Bond Count | 18 |
Drug Info: DrugBank
DrugBank ID | DB15449 |
---|---|
Name | Citarinostat |
Groups | investigational |
Description | Citarinostat is under investigation in clinical trial NCT02886065 (A Study of PVX-410, a Cancer Vaccine, and Citarinostat +/- Lenalidomide for Smoldering MM). |
Synonyms |
|
Categories |
|
CAS number | 1316215-12-9 |
Related Resource References
Resource Name | Reference |
---|---|
Pharos | CHEMBL3693786 |
PubChem | 53340426 |
ChEMBL | CHEMBL3693786 |